Literature DB >> 25373359

Renal sympathetic denervation for resistant hypertension: a transiently sustained placebo effect?

T E Purvis1, K E Shipman2, R Watkin3, J Freedman4, P Crowe4, I Dasgupta5.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25373359     DOI： 10.1038/jhh.2014.102

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  9 in total

1.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

2.  Renal artery stenosis after renal sympathetic denervation.

Authors:  Benjamin Kaltenbach; Dani Id; Jennifer C Franke; Horst Sievert; Marcus Hennersdorf; Jens Maier; Stefan C Bertog
Journal:  J Am Coll Cardiol       Date:  2012-11-07       Impact factor: 24.094

3.  Secondary rise in blood pressure after renal denervation.

Authors:  Oliver Vonend; Gerald Antoch; Lars Christian Rump; Dirk Blondin
Journal:  Lancet       Date:  2012-08-25       Impact factor: 79.321

4.  Resistant hypertension? Assessment of adherence by toxicological urine analysis.

Authors:  Oliver Jung; Janis L Gechter; Cora Wunder; Alexander Paulke; Christine Bartel; Helmut Geiger; Stefan W Toennes
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

5.  Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.

Authors:  Fadl Elmula Mohamed Fadl Elmula; Pavel Hoffmann; Eigil Fossum; Magne Brekke; Eyvind Gjønnæss; Ulla Hjørnholm; Vibeke N Kjær; Morten Rostrup; Sverre E Kjeldsen; Ingrid Os; Aud-E Stenehjem; Aud Høieggen
Journal:  Hypertension       Date:  2013-07-08       Impact factor: 10.190

6.  Does the presence of accessory renal arteries affect the efficacy of renal denervation?

Authors:  Dani Id; Benjamin Kaltenbach; Stefan C Bertog; Marius Hornung; Ilona Hofmann; Laura Vaskelyte; Horst Sievert
Journal:  JACC Cardiovasc Interv       Date:  2013-10       Impact factor: 11.195

7.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

8.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

9.  High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.

Authors:  Maciej Tomaszewski; Christobelle White; Prashanth Patel; Nicholas Masca; Ravi Damani; Joanne Hepworth; Nilesh J Samani; Pankaj Gupta; Webster Madira; Adrian Stanley; Bryan Williams
Journal:  Heart       Date:  2014-04-02       Impact factor: 5.994
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.